Form 4 for PTCT PTC THERAPEUTICS, INC.
Accepted 2023-01-09 00:00:00 ET · period of report 2023-01-05 · accession 0001415889-23-000673 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-01-09 | 2023-01-05 | PTCT | ZELDIS JEROME B | Dir | A - Grant | $0.00 | +4,000 | 10.5K | +62% | $0 |
| D | 2023-01-09 | 2023-01-05 | PTCT | ZELDIS JEROME B | Dir | A - Grant | $0.00 | +10.0K | 10.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-01-05 | A | A | 4,000 | $0.00 | 10,500 | D | — | — | (F1) Restricted stock units granted on January 5, 2023 that vest over one year, with five-twelfths (5/12) of the shares underlying the RSUs vesting on June 6, 2023 and the remaining seven-twelfths (7/12) of the original shares underlying the RSUs vesting on January 5, 2024. The Reporting Person has elected to defer receipt of all vested shares until the earliest to occur of (a) the date that is six months following separation of service from the Issuer, (b) a change in control event and (c) death. |
| 2 | Derivative | Stock Option (Right to Buy) | 2023-01-05 | A | A | 10,000 | $0.00 | 10,000 | D | $39.42 · — to 2033-01-04 | 10,000 Common Stock | (F2) This option was granted on January 5, 2023 and vests over one year in twelve equal monthly installments, commencing on February 5, 2023. |